| First Author | Lakkaraju AKK | Year | 2021 |
| Journal | EMBO Mol Med | Volume | 13 |
| Issue | 9 | Pages | e14714 |
| PubMed ID | 34291577 | Mgi Jnum | J:368589 |
| Mgi Id | MGI:6793851 | Doi | 10.15252/emmm.202114714 |
| Citation | Lakkaraju AKK, et al. (2021) Loss of PIKfyve drives the spongiform degeneration in prion diseases. EMBO Mol Med 13(9):e14714 |
| abstractText | Brain-matter vacuolation is a defining trait of all prion diseases, yet its cause is unknown. Here, we report that prion infection and prion-mimetic antibodies deplete the phosphoinositide kinase PIKfyve-which controls endolysosomal maturation-from mouse brains, cultured cells, organotypic brain slices, and brains of Creutzfeldt-Jakob disease victims. We found that PIKfyve is acylated by the acyltransferases zDHHC9 and zDHHC21, whose juxtavesicular topology is disturbed by prion infection, resulting in PIKfyve deacylation and rapid degradation, as well as endolysosomal hypertrophy and activation of TFEB-dependent lysosomal enzymes. A protracted unfolded protein response (UPR), typical of prion diseases, also induced PIKfyve deacylation and degradation. Conversely, UPR antagonists restored PIKfyve levels in prion-infected cells. Overexpression of zDHHC9 and zDHHC21, administration of the antiprion polythiophene LIN5044, or supplementation with the PIKfyve reaction product PI(3,5)P2 suppressed prion-induced vacuolation and restored lysosomal homeostasis. Thus, PIKfyve emerges as a central mediator of vacuolation and neurotoxicity in prion diseases. |
